Beyond Explantation: Early Seroma After Immediate Post-Mastectomy Implant-Based Breast Reconstruction - A Retrospective Cohort Study
This retrospective cohort study of 135 immediate implant-based breast reconstructions identifies axillary lymph node dissection and higher pre-removal drain output as key risk factors for early seroma, demonstrating that a stepwise management strategy can successfully salvage implants in 86.7% of cases without necessitating explantation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a woman undergoes a mastectomy, the removal of breast tissue due to cancer, surgeons often offer a way to rebuild the shape of the breast immediately afterward. This process, known as reconstruction, frequently involves placing a silicone implant under the skin or muscle to create a new breast mound. While this approach has become a standard part of modern cancer care, the body does not always accept the new implant without a fight. One of the most common hurdles is the formation of a seroma. This is a pocket of clear, watery fluid that the body produces in response to the surgery, collecting in the empty space left behind. If this fluid builds up, it can stretch the skin, delay healing, and in severe cases, force the removal of the implant, undoing the reconstruction. For years, the medical community has debated how to handle these fluid collections, often fearing that their presence signals a failed operation that requires taking the implant out.
A team of researchers at a cancer center in Italy set out to challenge this assumption by looking closely at what happens when these fluid pockets appear early after surgery. They reviewed the records of 115 women who had received 135 immediate breast reconstructions using implants between 2019 and 2025. The researchers defined an early seroma as any collection of fluid found within the first 30 days that required medical attention. Their goal was not just to count how often this happened, but to see if a careful, step-by-step approach could save the reconstruction instead of immediately removing the implant. They examined details such as the type of surgery performed on the lymph nodes under the arm, the patient's body weight, how long the surgical drains stayed in place, and how much fluid those drains removed before they were taken out.
The study found that early seromas occurred in about one out of every nine reconstructions. The risk was not the same for everyone; it was significantly higher for women who had a full removal of the lymph nodes under the arm compared to those who had a less invasive biopsy or no lymph node surgery at all. The researchers also noticed that women who developed these fluid collections tended to have a higher body mass index, and their surgical drains stayed in place longer, often draining more fluid in the final 24 hours before removal. Interestingly, the specific location of the implant, whether placed above or below the muscle, did not make a difference in who developed the fluid.
The most significant finding of the study was the outcome of the treatment. When a seroma appeared, the medical team did not rush to remove the implant. Instead, they used a graduated strategy. For simple cases, they drained the fluid with a needle. If the fluid returned or signs of infection appeared, they performed a surgical washout to clean the area. In many instances, they were able to keep the original implant. If the implant was compromised but the surrounding tissue was healthy, they swapped it for a new one during the same operation. Only in the most difficult cases, where the skin was dying or the infection was uncontrollable, did they have to remove the implant entirely. In the end, the team successfully saved the reconstruction in nearly nine out of ten cases where a seroma occurred.
This work suggests that the presence of fluid after breast reconstruction is not necessarily a dead end. While the risk of fluid collection is real, particularly for those with more extensive lymph node surgery, it does not automatically mean the end of the reconstruction. By monitoring the situation closely and intervening with a tailored plan that ranges from simple drainage to surgical cleaning, surgeons can often preserve the breast mound and maintain the continuity of the reconstruction. The study indicates that the decision to remove an implant should be based on the health of the surrounding tissue and the control of the infection, rather than the mere presence of fluid.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.